TUESDAY, Jan. 11, 2022 (HealthDay News) — It’s a move that could severely limit the number of people taking the controversial new Alzheimer’s drug Aduhelm: Medicare on Tuesday proposed to only cover the cost of the pricey medication for people enrolled in approved clinical trials. A final decision on coverageContinue Reading

MONDAY, Jan. 10, 2022 (HealthDay News) — Medicare has been told to reassess a significant premium increase it had announced that largely stemmed from the expensive new Alzheimer’s drug Aduhelm. U.S. Health and Human Services Secretary Xavier Becerra’s directive, which was announced on Monday, comes shortly after Aduhelm maker BiogenContinue Reading

FRIDAY, Jan. 7, 2022 (HealthDay News) — Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial Alzheimer’s drug Aduhelm. The drug’s benefits are in question and its annual price tag tops $28,000. The U.S. CentersContinue Reading

FRIDAY, Dec. 31, 2021 (HealthDay News) — A certain gene mutation known as APOE4 has long been known to raise the risk for Alzheimer’s disease. Now, researchers report it may also predispose people to increased susceptibility to COVID-19 infection and severe symptoms, including small brain bleeds. Researchers in Finland, whereContinue Reading

MONDAY, Dec. 20, 2021 (HealthDay News) — The maker of the pricey new Alzheimer’s drug Aduhelm (aducanumab) said Monday it will slash the cost of its medication in half, effective Jan. 1, 2022. The move follows widespread criticism of the drug’s original $56,000-a-year price tag. The reduction in the wholesaleContinue Reading

TUESDAY, Dec. 7, 2021 (HealthDay News) — People who undergo surgery to treat cataracts may have a lower likelihood of developing Alzheimer’s disease, a new study suggests. Of more than 3,000 older adults with the eye disease, those who had surgery were about 30% less likely to be diagnosed withContinue Reading

MONDAY, Dec. 6, 2021 (HealthDay News) — Checking older adults’ resting heart rate could help identify those who are more likely to experience a decline in mental function, a Swedish study suggests. The researchers found that a high resting heart rate was associated with a greater risk of dementia. “WeContinue Reading